Tenaya Therapeutics Statistics Share Statistics Tenaya Therapeutics has 162.67M
shares outstanding. The number of shares has increased by 106.2%
in one year.
Shares Outstanding 162.67M Shares Change (YoY) 106.2% Shares Change (QoQ) 0.05% Owned by Institutions (%) 43.84% Shares Floating 134.43M Failed to Deliver (FTD) Shares 8,265 FTD / Avg. Volume 0.34%
Short Selling Information The latest short interest is 10.2M, so 6.27% of the outstanding
shares have been sold short.
Short Interest 10.2M Short % of Shares Out 6.27% Short % of Float 17.28% Short Ratio (days to cover) 5.56
Valuation Ratios The PE ratio is -1.09 and the forward
PE ratio is -0.94.
Tenaya Therapeutics's PEG ratio is
0.05.
PE Ratio -1.09 Forward PE -0.94 PS Ratio 0 Forward PS 33.4 PB Ratio 1.31 P/FCF Ratio -1.33 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tenaya Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.22,
with a Debt / Equity ratio of 0.15.
Current Ratio 4.22 Quick Ratio 4.22 Debt / Equity 0.15 Debt / EBITDA -0.13 Debt / FCF -0.15 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.15M Employee Count 97 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -75% in the
last 52 weeks. The beta is 3.01, so Tenaya Therapeutics's
price volatility has been higher than the market average.
Beta 3.01 52-Week Price Change -75% 50-Day Moving Average 0.66 200-Day Moving Average 1.15 Relative Strength Index (RSI) 44.68 Average Volume (20 Days) 2,426,137
Income Statement
Revenue n/a Gross Profit n/a Operating Income -115.95M Net Income -111.13M EBITDA -102.66M EBIT -111.13M Earnings Per Share (EPS) -1.31
Full Income Statement Balance Sheet The company has 4.32M in cash and 13.61M in
debt, giving a net cash position of -9.29M.
Cash & Cash Equivalents 4.32M Total Debt 13.61M Net Cash -9.29M Retained Earnings -514.41M Total Assets 122.15M Working Capital 63.22M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -90.5M
and capital expenditures -1.02M, giving a free cash flow of -91.53M.
Operating Cash Flow -90.5M Capital Expenditures -1.02M Free Cash Flow -91.53M FCF Per Share -1.08
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
